2014
ReadPradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Comparative pharmaco-economic assessment of apixaban versus standard of care for the prevention of stroke in Italian atrial fibrillation patients. Farmeconomia. Health economics and therapeutic pathways 2014; 15(Suppl 1): 15-25 ReadPradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients....
2014
Goal Directed Perfusion (GDP): un’analisi dei costi differenziali in Italia. 7° Congresso Nazionale sihta, Rome, Italy, 25-27 September, 2014 What Are the Indicators of Cost-Effectiveness and Cost-Utility? ESPEN 36th Congress on Clinical Nutrition & Metabolism, Geneve, Switzerland, 6-9 September, 2014 Il giallo dell’autosufficienza. 10° Convention dei Centri Regionali del Sangue (CRS), Senigallia (AN), Italy, 12-14 June 2014 Pharmacoeconomics of Omega-3 Containing PN in ICU Patients. 42th Congress Hungarian Anesthesiology and Intensive Care Society...
2014
Zaniolo O, Povero M, Pradelli L, Pizzorno B, Mancini N. An Observational Propensity Score-Matched Study to Evaluate Cost-Effectiveness of a Real-Time PCR-Based Assay in Patients With Suspected Sepsis. ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014 Hashim MS, Povero M, Aliano A, Pradelli L. Economic Evaluation of Home Parenteral Nutriton in Cancer Patients; the French Context ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November,...
